Lv3
240 积分 2025-08-01 加入
Impact on carbamazepine usage and cutaneous adverse reactions before and after the reimbursement of HLA‐B*1502 genotyping in Taiwan, 2000–2017: A nationwide longitudinal study
2个月前
已完结
Associations of HLA and drug-metabolizing enzyme genes in co-trimoxazole-induced severe cutaneous adverse reactions
2个月前
已完结
Clinical features of and genetic predisposition to drug-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a single Korean tertiary institution patients—investigating the relation between the HLA -B*4403 allele and lamotrigine
2个月前
已关闭
Carbamazepine‐induced toxic epidermal necrolysis: the importance of HLA‐B*1502 testing in at‐risk populations prior to therapy initiation
2个月前
已完结
Association of HLA-B*1502 and *1511 allele with antiepileptic drug-induced Stevens-Johnson syndrome in central China
2个月前
已完结
Building pharmacogenetics into a pharmacovigilance program in Singapore: using serious skin rash as a pilot study
2个月前
已完结
Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China
2个月前
已完结
HLA‐B*1502 allele screening: Determination of carbamazepine‐induced cutaneous reactions
2个月前
已完结
Association between HLA genotype and antiseizure medications (ASMs)-induced maculopapular eruption among epilepsy patients in Xinjiang, China
2个月前
已完结
A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs
2个月前
已完结